eMed, which named Brady as its chief wellness officer earlier this year, offers GLP-1s, at-home blood testing and clinical consultations.
Pvolve's decision to launch a men's fitness class could speak to a larger trend to come in boutique fitness.
A Gallup survey reveals that the majority of Americans remain loyal to doctors and other medical professionals over AI tools, although Gen Z might be changing that dynamic.
Hims & Hers and Novo Nordisk are partners again, just weeks after Novo sued the telehealth giant for selling compounded GLP-1s.
Stanford’s sold-out event mapped the science and business models required to move preventive health beyond its early-adopter phase and into mass adoption.
Hims & Hers is planting its flag in new overseas markets; on U.S. soil, it's navigating a GLP-1s fight against Big Pharma's branded blockbusters.
Equinox members can use tax-free healthcare funds on select memberships, personal training, recovery services and women’s health programs.
Amazon just became the next major player to enter the biomarker blood testing wars with the launch of Health Insights.
Weight Watchers is the latest telehealth company to bundle pharma and fitness, a model that's quickly becoming the industry standard.
Apple is reportedly shelving its standalone “Health+” service, instead folding tools into Apple Health as competition in wearables and AI-driven wellness intensifies.
Sign Up to Our Newsletter
